PENWEST PHARMACEUTICALS CO 4
4 · PENWEST PHARMACEUTICALS CO · Filed Sep 27, 2010
Insider Transaction Report
Form 4
Transactions
- Disposition from Tender
Ordinary Shares
2010-09-20$5.00/sh−6,476,446$32,382,230→ 6,476,446 total(indirect: See footnotes)
Footnotes (2)
- [F1]This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund:), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as investment manager to the Master Fund. Mr. Edelman is the managing member of the Advisor and a member of the Board of Directors of the Issuer.
- [F2]This amount reflects the amount of securities held by the Master Fund immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by the Master Fund is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.